214 related articles for article (PubMed ID: 23643734)
1. Early stage epithelial ovarian cancers: a study of morphologic prognostic factors.
Terzi A; Aktaş IY; Dolgun A; Ayhan A; Küçükali T; Usubütün A
Pathol Res Pract; 2013 Jun; 209(6):359-64. PubMed ID: 23643734
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.
Liew PL; Hsu CS; Liu WM; Lee YC; Lee YC; Chen CL
Int J Clin Exp Pathol; 2015; 8(5):5642-9. PubMed ID: 26191276
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of microRNA-196a predicts poor prognosis in human ovarian carcinoma.
Fan Y; Fan J; Huang L; Ye M; Huang Z; Wang Y; Li Q; Huang J
Int J Clin Exp Pathol; 2015; 8(4):4132-7. PubMed ID: 26097603
[TBL] [Abstract][Full Text] [Related]
4. A novel nomogram based on LODDS to predict the prognosis of epithelial ovarian cancer.
Xu XL; Cheng H; Tang MS; Zhang HL; Wu RY; Yu Y; Li X; Wang XM; Mai J; Yang CL; Jiao L; Li ZL; Zhong ZM; Deng R; Li JD; Zhu XF
Oncotarget; 2017 Jan; 8(5):8120-8130. PubMed ID: 28042955
[TBL] [Abstract][Full Text] [Related]
5. Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer.
Barlin JN; Yu C; Hill EK; Zivanovic O; Kolev V; Levine DA; Sonoda Y; Abu-Rustum NR; Huh J; Barakat RR; Kattan MW; Chi DS
Gynecol Oncol; 2012 Apr; 125(1):25-30. PubMed ID: 22155261
[TBL] [Abstract][Full Text] [Related]
6. Improved 5-year disease-free survival for FIGO stage I epithelial ovarian cancer patients without tumor rupture during surgery.
Paulsen T; Kærn J; Tropé C
Gynecol Oncol; 2011 Jul; 122(1):83-8. PubMed ID: 21435701
[TBL] [Abstract][Full Text] [Related]
7. Nuclear β-catenin positivity as a predictive marker of long-term survival in advanced epithelial ovarian cancer.
Nagy B; Tóth L; Molnár P; Méhes G; Thurzó L; Póka R; Hernádi Z
Pathol Res Pract; 2017 Aug; 213(8):915-921. PubMed ID: 28651933
[TBL] [Abstract][Full Text] [Related]
8. Comparison Of Early-Stage High-Grade Serous Primary Fallopian Tube Cancers and Epithelial Ovarian Cancers: A Multicenter Study.
Gungorduk K; Ozdemir A; Selcuk I; Telli E; Şahin Ö; Toptaş T; Akman L; Güzel AB; Taşkın S; Öge T; Güngördük Ö; Gokçü M; Gungor T; Yaşar L; Terek MC; Ozan H; Ozsaran A; Sancı M; Vardar MA; Meydanlı MM; Yalçın ÖT; Ortac F; Özalp S
Oncol Res Treat; 2017; 40(4):203-206. PubMed ID: 28376498
[TBL] [Abstract][Full Text] [Related]
9. Toward the development of a universal grading system for ovarian epithelial carcinoma. I. Prognostic significance of histopathologic features--problems involved in the architectural grading system.
Shimizu Y; Kamoi S; Amada S; Hasumi K; Akiyama F; Silverberg SG
Gynecol Oncol; 1998 Jul; 70(1):2-12. PubMed ID: 9698465
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of residual tumor size in patients with epithelial ovarian cancer FIGO stages IIA-IV: analysis of the OVCAD data.
Polterauer S; Vergote I; Concin N; Braicu I; Chekerov R; Mahner S; Woelber L; Cadron I; Van Gorp T; Zeillinger R; Castillo-Tong DC; Sehouli J
Int J Gynecol Cancer; 2012 Mar; 22(3):380-5. PubMed ID: 22266934
[TBL] [Abstract][Full Text] [Related]
11. The safety of postoperative hormone replacement therapy in epithelial ovarian cancer patients in China.
Wen Y; Huang H; Huang H; Wu M; Shen K; Pan L
Climacteric; 2013 Dec; 16(6):673-81. PubMed ID: 23710587
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC;
Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296
[TBL] [Abstract][Full Text] [Related]
13. The revised 2014 FIGO staging system for epithelial ovarian cancer: Is a subclassification into FIGO stage IVA and IVB justified?
Ataseven B; Harter P; Grimm C; Heitz F; Heikaus S; Traut A; Kahl A; Kurzeder C; Prader S; du Bois A
Gynecol Oncol; 2016 Aug; 142(2):243-7. PubMed ID: 27208538
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic Versus Laparotomic Surgical Staging for Early-Stage Ovarian Cancer: A Case-Control Study.
Gallotta V; Petrillo M; Conte C; Vizzielli G; Fagotti A; Ferrandina G; Fanfani F; Costantini B; Carbone V; Scambia G
J Minim Invasive Gynecol; 2016; 23(5):769-74. PubMed ID: 26995493
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of MAGE-A9 Is Predictive of Poor Prognosis in Epithelial Ovarian Cancer.
Xu Y; Wang C; Zhang Y; Jia L; Huang J
Sci Rep; 2015 Jul; 5():12104. PubMed ID: 26175056
[TBL] [Abstract][Full Text] [Related]
16. A new prognostic index model using meta-analysis in early-stage epithelial ovarian cancer.
Park HJ; Nam EJ; Rha SY; Kim S; Kim SW; Kim JW; Kim YT
Gynecol Oncol; 2012 Sep; 126(3):357-63. PubMed ID: 22687686
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study.
Heeran MC; Høgdall CK; Kjaer SK; Christensen L; Jensen A; Blaakaer J; Christensen IJ; Høgdall EV
APMIS; 2013 Dec; 121(12):1177-86. PubMed ID: 23594232
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of residual tumor in patients with epithelial ovarian carcinoma stage IV in a 20 year perspective.
Elstrand MB; Sandstad B; Oksefjell H; Davidson B; Tropé CG
Acta Obstet Gynecol Scand; 2012 Mar; 91(3):308-17. PubMed ID: 22050605
[TBL] [Abstract][Full Text] [Related]
19. The influence of intraoperative tumor rupture on recurrence risk in Stage Ic epithelial ovarian cancer.
Goudge CS; Li Z; Downs LS
Eur J Gynaecol Oncol; 2009; 30(1):25-8. PubMed ID: 19317252
[TBL] [Abstract][Full Text] [Related]
20. Clear cell carcinomas of the ovary: a mono-institutional study of 73 cases in China with an analysis of the prognostic significance of clinicopathological parameters and IMP3 expression.
Bi R; Shen X; Zhang W; Cheng Y; Feng Z; Cai X; Yang W
Diagn Pathol; 2016 Feb; 11():17. PubMed ID: 26837693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]